VFEND (Cardinal Health)
Welcome to the PulseAid listing for the VFEND drug offered from Cardinal Health. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cardinal Health |
| NON-PROPRIETARY NAME: | voriconazole |
| SUBSTANCE NAME: | VORICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-05-24 |
| END MARKETING DATE: | 0000-00-00 |
VFEND HUMAN PRESCRIPTION DRUG Details:
| Item Description | VFEND from Cardinal Health |
| LABELER NAME: | Cardinal Health |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2002-05-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55154-2725_c9a9b2de-dae1-411c-a13e-8b445ff993ff |
| PRODUCT NDC: | 55154-2725 |
| APPLICATION NUMBER: | NDA021266 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers:
